9 Newly Approved Novel Drugs
It's been a busy year for the FDA.
5. Xermelo (telotristat ethyl), Lexicon Pharmaceuticals, Inc.
Indications: A tryptophan hydroxylase inhibitor indicated for carcinoid syndrome diarrhea in combination with somatostatin analog (SSA) therapy in adults whose diarrhea is adquately controlled by SSA therapy.
Dosage: 250 mg tid with food.